Global Brain Cancer Diagnostics Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18749833

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18749833

Global Brain Cancer Diagnostics Databank Market Report

The Brain Cancer Diagnostics market was valued at $2,125.6 Million in 2022, and is projected to reach $3,886.5 Million by 2031 growing at a CAGR of 6.98% from 2023 to 2031. Imaging Test segment is expected to be the highest contributor to this market, with $694.7 Million in 2022, and is anticipated to reach $1,223.4 Million by 2031, registering a CAGR of 6.54%. Molecular Testing segment is anticipated to reach $629.6 Million by 2031 with the highest CAGR of 8.34%. Imaging Test and Lumbar Puncture segments collectively expected to account for about 58.9% share of the Brain Cancer Diagnostics market in 2022, with the former constituting around 32.7% share. Molecular Testing and Lumbar Puncture segments are expected to witness significant growth rates at a CAGR of 8.34% and 7.35% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 40.7% in the overall Brain Cancer Diagnostics market in 2022, and is anticipated to reach 43.3% by 2031.

1. Global Brain Cancer Diagnostics Market, By Diagnostic Type: 1.1. Overview; 1.2. Imaging Test; 1.2.1 Imaging Test Market, By Region; 1.2.1.1 North America Imaging Test Market, By Country; 1.2.1.2 Europe Imaging Test Market, By Country; 1.2.1.3 Asia-Pacific Imaging Test Market, By Country; 1.2.1.4 Rest of World Imaging Test Market, By Country; 1.3. Lumbar Puncture; 1.3.1 Lumbar Puncture Market, By Region; 1.3.1.1 North America Lumbar Puncture Market, By Country; 1.3.1.2 Europe Lumbar Puncture Market, By Country; 1.3.1.3 Asia-Pacific Lumbar Puncture Market, By Country; 1.3.1.4 Rest of World Lumbar Puncture Market, By Country; 1.4. Biopsy; 1.4.1 Biopsy Market, By Region; 1.4.1.1 North America Biopsy Market, By Country; 1.4.1.2 Europe Biopsy Market, By Country; 1.4.1.3 Asia-Pacific Biopsy Market, By Country; 1.4.1.4 Rest of World Biopsy Market, By Country; 1.5. Molecular Testing; 1.5.1 Molecular Testing Market, By Region; 1.5.1.1 North America Molecular Testing Market, By Country; 1.5.1.2 Europe Molecular Testing Market, By Country; 1.5.1.3 Asia-Pacific Molecular Testing Market, By Country; 1.5.1.4 Rest of World Molecular Testing Market, By Country; 1.6. Other Diagnostic Types; 1.6.1 Other Diagnostic Types Market, By Region; 1.6.1.1 North America Other Diagnostic Types Market, By Country; 1.6.1.2 Europe Other Diagnostic Types Market, By Country; 1.6.1.3 Asia-Pacific Other Diagnostic Types Market, By Country; 1.6.1.4 Rest of World Other Diagnostic Types Market, By Country
2. Global Brain Cancer Diagnostics Market, By Tumor Type: 2.1. Overview; 2.2. Metastatic; 2.2.1 Metastatic Market, By Region; 2.2.1.1 North America Metastatic Market, By Country; 2.2.1.2 Europe Metastatic Market, By Country; 2.2.1.3 Asia-Pacific Metastatic Market, By Country; 2.2.1.4 Rest of World Metastatic Market, By Country; 2.3. Meningioma; 2.3.1 Meningioma Market, By Region; 2.3.1.1 North America Meningioma Market, By Country; 2.3.1.2 Europe Meningioma Market, By Country; 2.3.1.3 Asia-Pacific Meningioma Market, By Country; 2.3.1.4 Rest of World Meningioma Market, By Country; 2.4. Gliblastoma; 2.4.1 Gliblastoma Market, By Region; 2.4.1.1 North America Gliblastoma Market, By Country; 2.4.1.2 Europe Gliblastoma Market, By Country; 2.4.1.3 Asia-Pacific Gliblastoma Market, By Country; 2.4.1.4 Rest of World Gliblastoma Market, By Country; 2.5. Pituitary Endoma; 2.5.1 Pituitary Endoma Market, By Region; 2.5.1.1 North America Pituitary Endoma Market, By Country; 2.5.1.2 Europe Pituitary Endoma Market, By Country; 2.5.1.3 Asia-Pacific Pituitary Endoma Market, By Country; 2.5.1.4 Rest of World Pituitary Endoma Market, By Country; 2.6. Other Tumor Types; 2.6.1 Other Tumor Types Market, By Region; 2.6.1.1 North America Other Tumor Types Market, By Country; 2.6.1.2 Europe Other Tumor Types Market, By Country; 2.6.1.3 Asia-Pacific Other Tumor Types Market, By Country; 2.6.1.4 Rest of World Other Tumor Types Market, By Country
3. Global Brain Cancer Diagnostics Market, By End User: 3.1. Overview; 3.2. Hospitals; 3.2.1 Hospitals Market, By Region; 3.2.1.1 North America Hospitals Market, By Country; 3.2.1.2 Europe Hospitals Market, By Country; 3.2.1.3 Asia-Pacific Hospitals Market, By Country; 3.2.1.4 Rest of World Hospitals Market, By Country; 3.3. Diagnostic Centers; 3.3.1 Diagnostic Centers Market, By Region; 3.3.1.1 North America Diagnostic Centers Market, By Country; 3.3.1.2 Europe Diagnostic Centers Market, By Country; 3.3.1.3 Asia-Pacific Diagnostic Centers Market, By Country; 3.3.1.4 Rest of World Diagnostic Centers Market, By Country; 3.4. Other End Users; 3.4.1 Other End Users Market, By Region; 3.4.1.1 North America Other End Users Market, By Country; 3.4.1.2 Europe Other End Users Market, By Country; 3.4.1.3 Asia-Pacific Other End Users Market, By Country; 3.4.1.4 Rest of World Other End Users Market, By Country
4. Global Brain Cancer Diagnostics Market, By Region: 4.1. Overview; 4.2. North America; 4.2.1 North America Brain Cancer Diagnostics Market, By Diagnostic Type; 4.2.2 North America Brain Cancer Diagnostics Market, By Tumor Type; 4.2.3 North America Brain Cancer Diagnostics Market, By End User; 4.2.4 North America Brain Cancer Diagnostics Market, By Country; 4.2.4.1 U.S.; 4.2.4.1.1 U.S. Brain Cancer Diagnostics Market, By Diagnostic Type; 4.2.4.1.2 U.S. Brain Cancer Diagnostics Market, By Tumor Type; 4.2.4.1.3 U.S. Brain Cancer Diagnostics Market, By End User; 4.2.4.2 Canada; 4.2.4.2.1 Canada Brain Cancer Diagnostics Market, By Diagnostic Type; 4.2.4.2.2 Canada Brain Cancer Diagnostics Market, By Tumor Type; 4.2.4.2.3 Canada Brain Cancer Diagnostics Market, By End User; 4.3. Europe; 4.3.1 Europe Brain Cancer Diagnostics Market, By Diagnostic Type; 4.3.2 Europe Brain Cancer Diagnostics Market, By Tumor Type; 4.3.3 Europe Brain Cancer Diagnostics Market, By End User; 4.3.4 Europe Brain Cancer Diagnostics Market, By Country; 4.3.4.1 Germany; 4.3.4.1.1 Germany Brain Cancer Diagnostics Market, By Diagnostic Type; 4.3.4.1.2 Germany Brain Cancer Diagnostics Market, By Tumor Type; 4.3.4.1.3 Germany Brain Cancer Diagnostics Market, By End User; 4.3.4.2 U.K.; 4.3.4.2.1 U.K. Brain Cancer Diagnostics Market, By Diagnostic Type; 4.3.4.2.2 U.K. Brain Cancer Diagnostics Market, By Tumor Type; 4.3.4.2.3 U.K. Brain Cancer Diagnostics Market, By End User; 4.3.4.3 France; 4.3.4.3.1 France Brain Cancer Diagnostics Market, By Diagnostic Type; 4.3.4.3.2 France Brain Cancer Diagnostics Market, By Tumor Type; 4.3.4.3.3 France Brain Cancer Diagnostics Market, By End User; 4.3.4.4 Italy; 4.3.4.4.1 Italy Brain Cancer Diagnostics Market, By Diagnostic Type; 4.3.4.4.2 Italy Brain Cancer Diagnostics Market, By Tumor Type; 4.3.4.4.3 Italy Brain Cancer Diagnostics Market, By End User; 4.3.4.5 Spain; 4.3.4.5.1 Spain Brain Cancer Diagnostics Market, By Diagnostic Type; 4.3.4.5.2 Spain Brain Cancer Diagnostics Market, By Tumor Type; 4.3.4.5.3 Spain Brain Cancer Diagnostics Market, By End User; 4.3.4.6 Rest of Europe; 4.3.4.6.1 Rest of Europe Brain Cancer Diagnostics Market, By Diagnostic Type; 4.3.4.6.2 Rest of Europe Brain Cancer Diagnostics Market, By Tumor Type; 4.3.4.6.3 Rest of Europe Brain Cancer Diagnostics Market, By End User; 4.4. Asia-Pacific; 4.4.1 Asia-Pacific Brain Cancer Diagnostics Market, By Diagnostic Type; 4.4.2 Asia-Pacific Brain Cancer Diagnostics Market, By Tumor Type; 4.4.3 Asia-Pacific Brain Cancer Diagnostics Market, By End User; 4.4.4 Asia-Pacific Brain Cancer Diagnostics Market, By Country; 4.4.4.1 China; 4.4.4.1.1 China Brain Cancer Diagnostics Market, By Diagnostic Type; 4.4.4.1.2 China Brain Cancer Diagnostics Market, By Tumor Type; 4.4.4.1.3 China Brain Cancer Diagnostics Market, By End User; 4.4.4.2 Japan; 4.4.4.2.1 Japan Brain Cancer Diagnostics Market, By Diagnostic Type; 4.4.4.2.2 Japan Brain Cancer Diagnostics Market, By Tumor Type; 4.4.4.2.3 Japan Brain Cancer Diagnostics Market, By End User; 4.4.4.3 South Korea; 4.4.4.3.1 South Korea Brain Cancer Diagnostics Market, By Diagnostic Type; 4.4.4.3.2 South Korea Brain Cancer Diagnostics Market, By Tumor Type; 4.4.4.3.3 South Korea Brain Cancer Diagnostics Market, By End User; 4.4.4.4 India; 4.4.4.4.1 India Brain Cancer Diagnostics Market, By Diagnostic Type; 4.4.4.4.2 India Brain Cancer Diagnostics Market, By Tumor Type; 4.4.4.4.3 India Brain Cancer Diagnostics Market, By End User; 4.4.4.5 Singapore; 4.4.4.5.1 Singapore Brain Cancer Diagnostics Market, By Diagnostic Type; 4.4.4.5.2 Singapore Brain Cancer Diagnostics Market, By Tumor Type; 4.4.4.5.3 Singapore Brain Cancer Diagnostics Market, By End User; 4.4.4.6 Rest of Asia; 4.4.4.6.1 Rest of Asia Brain Cancer Diagnostics Market, By Diagnostic Type; 4.4.4.6.2 Rest of Asia Brain Cancer Diagnostics Market, By Tumor Type; 4.4.4.6.3 Rest of Asia Brain Cancer Diagnostics Market, By End User; 4.5. Rest of World; 4.5.1 Rest of World Brain Cancer Diagnostics Market, By Diagnostic Type; 4.5.2 Rest of World Brain Cancer Diagnostics Market, By Tumor Type; 4.5.3 Rest of World Brain Cancer Diagnostics Market, By End User; 4.5.4 Rest of World Brain Cancer Diagnostics Market, By Country; 4.5.4.1 Brazil; 4.5.4.1.1 Brazil Brain Cancer Diagnostics Market, By Diagnostic Type; 4.5.4.1.2 Brazil Brain Cancer Diagnostics Market, By Tumor Type; 4.5.4.1.3 Brazil Brain Cancer Diagnostics Market, By End User; 4.5.4.2 Mexico; 4.5.4.2.1 Mexico Brain Cancer Diagnostics Market, By Diagnostic Type; 4.5.4.2.2 Mexico Brain Cancer Diagnostics Market, By Tumor Type; 4.5.4.2.3 Mexico Brain Cancer Diagnostics Market, By End User; 4.5.4.3 South Africa; 4.5.4.3.1 South Africa Brain Cancer Diagnostics Market, By Diagnostic Type; 4.5.4.3.2 South Africa Brain Cancer Diagnostics Market, By Tumor Type; 4.5.4.3.3 South Africa Brain Cancer Diagnostics Market, By End User; 4.5.4.4 Australia; 4.5.4.4.1 Australia Brain Cancer Diagnostics Market, By Diagnostic Type; 4.5.4.4.2 Australia Brain Cancer Diagnostics Market, By Tumor Type; 4.5.4.4.3 Australia Brain Cancer Diagnostics Market, By End User; 4.5.4.5 ROW Countries; 4.5.4.5.1 ROW Countries Brain Cancer Diagnostics Market, By Diagnostic Type; 4.5.4.5.2 ROW Countries Brain Cancer Diagnostics Market, By Tumor Type; 4.5.4.5.3 ROW Countries Brain Cancer Diagnostics Market, By End User; ROW Countries Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 2. Imaging Test Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Imaging Test Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Imaging Test Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Imaging Test Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Imaging Test Market Value, By Country, 2022-2031, Million USD; TABLE 7. Lumbar Puncture Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Lumbar Puncture Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Lumbar Puncture Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Lumbar Puncture Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Lumbar Puncture Market Value, By Country, 2022-2031, Million USD; TABLE 12. Biopsy Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Biopsy Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Biopsy Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Biopsy Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Biopsy Market Value, By Country, 2022-2031, Million USD; TABLE 17. Molecular Testing Market Value, By Region, 2022-2031, Million USD; TABLE 18. North America Molecular Testing Market Value, By Country, 2022-2031, Million USD; TABLE 19. Europe Molecular Testing Market Value, By Country, 2022-2031, Million USD; TABLE 20. Asia-Pacific Molecular Testing Market Value, By Country, 2022-2031, Million USD; TABLE 21. Rest of World Molecular Testing Market Value, By Country, 2022-2031, Million USD; TABLE 22. Other Diagnostic Types Market Value, By Region, 2022-2031, Million USD; TABLE 23. North America Other Diagnostic Types Market Value, By Country, 2022-2031, Million USD; TABLE 24. Europe Other Diagnostic Types Market Value, By Country, 2022-2031, Million USD; TABLE 25. Asia-Pacific Other Diagnostic Types Market Value, By Country, 2022-2031, Million USD; TABLE 26. Rest of World Other Diagnostic Types Market Value, By Country, 2022-2031, Million USD; TABLE 27. Global Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 28. Metastatic Market Value, By Region, 2022-2031, Million USD; TABLE 29. North America Metastatic Market Value, By Country, 2022-2031, Million USD; TABLE 30. Europe Metastatic Market Value, By Country, 2022-2031, Million USD; TABLE 31. Asia-Pacific Metastatic Market Value, By Country, 2022-2031, Million USD; TABLE 32. Rest of World Metastatic Market Value, By Country, 2022-2031, Million USD; TABLE 33. Meningioma Market Value, By Region, 2022-2031, Million USD; TABLE 34. North America Meningioma Market Value, By Country, 2022-2031, Million USD; TABLE 35. Europe Meningioma Market Value, By Country, 2022-2031, Million USD; TABLE 36. Asia-Pacific Meningioma Market Value, By Country, 2022-2031, Million USD; TABLE 37. Rest of World Meningioma Market Value, By Country, 2022-2031, Million USD; TABLE 38. Gliblastoma Market Value, By Region, 2022-2031, Million USD; TABLE 39. North America Gliblastoma Market Value, By Country, 2022-2031, Million USD; TABLE 40. Europe Gliblastoma Market Value, By Country, 2022-2031, Million USD; TABLE 41. Asia-Pacific Gliblastoma Market Value, By Country, 2022-2031, Million USD; TABLE 42. Rest of World Gliblastoma Market Value, By Country, 2022-2031, Million USD; TABLE 43. Pituitary Endoma Market Value, By Region, 2022-2031, Million USD; TABLE 44. North America Pituitary Endoma Market Value, By Country, 2022-2031, Million USD; TABLE 45. Europe Pituitary Endoma Market Value, By Country, 2022-2031, Million USD; TABLE 46. Asia-Pacific Pituitary Endoma Market Value, By Country, 2022-2031, Million USD; TABLE 47. Rest of World Pituitary Endoma Market Value, By Country, 2022-2031, Million USD; TABLE 48. Other Tumor Types Market Value, By Region, 2022-2031, Million USD; TABLE 49. North America Other Tumor Types Market Value, By Country, 2022-2031, Million USD; TABLE 50. Europe Other Tumor Types Market Value, By Country, 2022-2031, Million USD; TABLE 51. Asia-Pacific Other Tumor Types Market Value, By Country, 2022-2031, Million USD; TABLE 52. Rest of World Other Tumor Types Market Value, By Country, 2022-2031, Million USD; TABLE 53. Global Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 54. Hospitals Market Value, By Region, 2022-2031, Million USD; TABLE 55. North America Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 56. Europe Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 57. Asia-Pacific Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 58. Rest of World Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 59. Diagnostic Centers Market Value, By Region, 2022-2031, Million USD; TABLE 60. North America Diagnostic Centers Market Value, By Country, 2022-2031, Million USD; TABLE 61. Europe Diagnostic Centers Market Value, By Country, 2022-2031, Million USD; TABLE 62. Asia-Pacific Diagnostic Centers Market Value, By Country, 2022-2031, Million USD; TABLE 63. Rest of World Diagnostic Centers Market Value, By Country, 2022-2031, Million USD; TABLE 64. Other End Users Market Value, By Region, 2022-2031, Million USD; TABLE 65. North America Other End Users Market Value, By Country, 2022-2031, Million USD; TABLE 66. Europe Other End Users Market Value, By Country, 2022-2031, Million USD; TABLE 67. Asia-Pacific Other End Users Market Value, By Country, 2022-2031, Million USD; TABLE 68. Rest of World Other End Users Market Value, By Country, 2022-2031, Million USD; TABLE 69. Global Brain Cancer Diagnostics Market Value, By Region, 2022-2031, Million USD; TABLE 70. North America Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 71. North America Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 72. North America Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 73. North America Brain Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD; TABLE 74. U.S. Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 75. U.S. Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 76. U.S. Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 77. Canada Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 78. Canada Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 79. Canada Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 80. Europe Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 81. Europe Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 82. Europe Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 83. Europe Brain Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD; TABLE 84. Germany Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 85. Germany Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 86. Germany Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 87. U.K. Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 88. U.K. Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 89. U.K. Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 90. France Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 91. France Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 92. France Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 93. Italy Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 94. Italy Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 95. Italy Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 96. Spain Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 97. Spain Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 98. Spain Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 99. Rest of Europe Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 100. Rest of Europe Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 101. Rest of Europe Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 102. Asia-Pacific Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 103. Asia-Pacific Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 104. Asia-Pacific Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 105. Asia-Pacific Brain Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD; TABLE 106. China Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 107. China Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 108. China Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 109. Japan Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 110. Japan Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 111. Japan Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 112. South Korea Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 113. South Korea Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 114. South Korea Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 115. India Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 116. India Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 117. India Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 118. Singapore Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 119. Singapore Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 120. Singapore Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 121. Rest of Asia Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 122. Rest of Asia Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 123. Rest of Asia Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 124. Rest of World Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 125. Rest of World Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 126. Rest of World Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 127. Rest of World Brain Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD; TABLE 128. Brazil Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 129. Brazil Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 130. Brazil Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 131. Mexico Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 132. Mexico Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 133. Mexico Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 134. South Africa Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 135. South Africa Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 136. South Africa Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 137. Australia Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 138. Australia Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 139. Australia Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; TABLE 140. ROW Countries Brain Cancer Diagnostics Market Value, By Diagnostic Type, 2022-2031, Million USD; TABLE 141. ROW Countries Brain Cancer Diagnostics Market Value, By Tumor Type, 2022-2031, Million USD; TABLE 142. ROW Countries Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD; ROW Countries Brain Cancer Diagnostics Market Value, By End User, 2022-2031, Million USD